Health Populi

MARCH 11, 2021

[Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

OCTOBER 28, 2019

A recent study on politics and health care spending in the U.S. published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. Congress and healthcare spending.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

JUNE 18, 2020

The authors, Dr. Naci and Dr. Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn to $9.9 bn for Medicaid.

BioTech 191

BioTech Medicare Life Science Telehealth 191

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. One of the only issues bringing people together in the U.S.

Pharmaceuticals 140

Pharmaceuticals Life Science Medicare BioTech 140

Health Populi

JUNE 3, 2021

adults note that expanding Medicare to including hearing aids, dental and vision coverage would be their top or an important priority, shown in the second line in the bar chart on public priorities. States to negotiate with drug companies to get lower prices on Rx meds in their state, and. On the cost-front, 90% of U.S.

Medicare 170

Medicare Life Science BioTech Pharmaceuticals 170

Health Populi

MAY 19, 2019

They don’t tend to shop around for health care or be super-engaged in their care, probably because they tend to be older and more likely to be covered by Medicare. They may be threatened by a call for “Medicare for All” given their affection for the program.

Life Science 149

Life Science BioTech Medicare Medical Billing 149